0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 81-100 of 895 Articles
JAMA Dermatology | 
Observation | 
Dominique C. Pichard, MD; Adela R. Cardones, MD; Emily Y. Chu, MD, PhD; et al.
JAMA Dermatol. 2016;152(2):227-228. doi:10.1001/jamadermatol.2015.2930.

JAMA Oncology | 
Original Investigation | 
Mark Clemons, MD; Nathaniel Bouganim, MD; Stephanie Smith, BA; et al.
JAMA Oncol. 2016;2(2):225-231. doi:10.1001/jamaoncol.2015.3730.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Veronica J. Shi, BA; Anjela Galan, MD; Ian D. Odell, MD, PhD; et al.
JAMA Dermatol. 2016;152(2):222-223. doi:10.1001/jamadermatol.2015.3209.

JAMA Dermatology | 
Observation | 
Xinyi Yang; Scott M. Dinehart, MD
JAMA Dermatol. 2016;152(2):223-224. doi:10.1001/jamadermatol.2015.3210.

JAMA Dermatology | 
Original Investigation | 
Frank I. Scott, MD, MSCE; Ronac Mamtani, MD, MSCE; Colleen M. Brensinger, MS; et al.
JAMA Dermatol. 2016;152(2):164-172. doi:10.1001/jamadermatol.2015.3029.
Includes: Supplemental Content

JAMA Oncology | 
JAMA Oncology Diagnostic Test Interpretation | 
Nibal Rizk, MD; Carlos Kamiya-Matsuoka, MD; Ivo W. Tremont-Lukats, MD
JAMA Oncol. 2016;2(2):265-266. doi:10.1001/jamaoncol.2015.4301.

JAMA Pediatrics | 
Editorial | 
Bryan H. King, MD, MBA
JAMA Pediatr. 2016;170(2):111-112. doi:10.1001/jamapediatrics.2015.3493.

JAMA Pediatrics | 
Original Investigation | 
Takoua Boukhris, MSc; Odile Sheehy, MSc; Laurent Mottron, MD, PhD; et al.
JAMA Pediatr. 2016;170(2):117-124. doi:10.1001/jamapediatrics.2015.3356.
Includes: CME, Supplemental Content

JAMA Oncology | 
Original Investigation | 
Douglas B. Johnson, MD; Ryan J. Sullivan, MD; Patrick A. Ott, MD, PhD; et al.
JAMA Oncol. 2016;2(2):234-240. doi:10.1001/jamaoncol.2015.4368.
Includes: Supplemental Content

JAMA Oncology | 
Editor's Note |  FREE
Mary L. Disis, MD
JAMA Oncol. 2016;2(2):241. doi:10.1001/jamaoncol.2015.4717.

JAMA Neurology | 
Images in Neurology | 
Derek M. Sorensen, MD
JAMA Neurol. 2016;73(2):232-233. doi:10.1001/jamaneurol.2015.3472.

JAMA Neurology | 
Editorial | 
Stephan A. Mayer, MD
JAMA Neurol. 2016;73(2):155-156. doi:10.1001/jamaneurol.2015.3884.

JAMA Neurology | 
Original Investigation | 
Jan C. Purrucker, MD; Kirsten Haas, MPH, PhD; Timolaos Rizos, MD; et al.
JAMA Neurol. 2016;73(2):169-177. doi:10.1001/jamaneurol.2015.3682.
Includes: Supplemental Content

JAMA Otolaryngology–Head & Neck Surgery | 
Original Investigation | 
Andrew Nida, MD; Josie Alston, MS; John Schweinfurth, MD
JAMA Otolaryngol Head Neck Surg. 2016;142(2):117-121. doi:10.1001/jamaoto.2015.2849.
Includes: CME

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5392
Includes: Supplemental Content

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18729.

JAMA Internal Medicine | 
Viewpoint | 
Anna Hung, PharmD; Jan Sieluk, MPharm; Peter Doshi, PhD
JAMA Intern Med. 2016;176(1):11-12. doi:10.1001/jamainternmed.2015.6656.

JAMA Internal Medicine | 
Teachable Moment | 
Nathan Handley, MD; Alon Unger, MD
JAMA Intern Med. 2016;176(1):19-20. doi:10.1001/jamainternmed.2015.6527.

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib A Phase 2 Clinical Trial
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncology
Research Letter  | 
Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncology
Original Investigation  | 
Cardiovascular Disease After Aromatase Inhibitor Use
Reina Haque, PhD; Jiaxiao Shi, PhD; Joanne E. Schottinger, MD; et al.
JAMA Dermatology
Original Investigation  | 
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma A Systematic Review and Pooled Analysis of Interventional Studies
Audrey A. Jacobsen, BA; Adam S. Aldahan, BS; Olivia B. Hughes, BS; et al.